 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Ramesh T. on LIVE DISCUSSION: Mice on Trial? Issues in the Design of Drug Studies, Based on the large scale analysis of survival in the Bl6/SJL mixed hybrid strain of SOD1 G93A... 30 May 2008.
|
|
|
 |
|
|
Ramesh T. on PAPER: Angelov DN. et al., 2003, The role of the immune system in ALS remains very controversial. Recent advances in... 8 Apr 2003.
|
|
|
|
|
|
Ramesh T. on NEWS: ALS—Could Stability Rather than Activity of SOD Hold the Key?, First of all I must admit that I am not an expert on the dynamics of SOD protein folding. In... 4 Dec 2002.
|
|
|
|
|
|
Ramesh T. on NEWS: Tubulin Chaperone Found to Cause Rare Motor Neuron Degeneration, and More, This paper mixes well with the 28 Oct 2002.
|
|
|
|
|
|
Ramesh T. on NEWS: Dynamitin in Motor Neurons: Dynamite for ALS Research?, The paper by LaMonte et al. adds a new twist to the complex history of axonal transport in ALS. ... 31 May 2002.
|
|
|
|
|
|
Ramesh T. on LIVE DISCUSSION: The Cell Cycle and Alzheimer’s Disease—Let's Unite for Division!, Reply by Tennore Ramesh
I agree with Dr. Wolozin. Many cell cycle proteins are... 31 May 2002.
|
|
|
|
|
|
Ramesh T. on LIVE DISCUSSION: The Cell Cycle and Alzheimer’s Disease—Let's Unite for Division!, I wanted to join this the very interesting discussion but was unable to do so. As researcher at... 29 May 2002.
|
|
|
|
|
|
Ramesh T. on NEWS: Disputing the Dismuting—What Is the Real Role of SOD in ALS?, Contrary to assumptions that mutant superoxide dismutase (mSOD) causes ALS via... 18 Mar 2002.
|
|
|
|
|
|
Ramesh T. on LIVE DISCUSSION: From Epidemiology to Therapeutic Trials with Anti-inflammatory Drugs in Alzheimer's Disease: The Role of NSAIDs and Cyclooxygenase on Beta-amyloidosis and Clinical Dementia, It appears that expression of Cox-1 and 2 varies with species, dose, route
and type of insult.... 15 Mar 2002.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
